CinCor Pharma Inc

NASDAQ:CINC  
20.28
+1.44 (+7.64%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

CinCor Pharma Inc Stock, NASDAQ:CINC

230 3rd Avenue, 6th floor, Waltham, Massachusetts 02451
United States of America
Phone: +1.844.531.1834
Number of Employees: 15

Description

CinCor Pharma, Inc. operates as a clinical-stage biopharmaceutical company focused on developing its clinical candidate, CIN-107, for the treatment of hypertension and other cardio-renal diseases. The firm is developing CIN-107 for the treatment of multiple diseases where aldosterone plays a significant role in disease pathophysiology, including hypertension and primary aldosteronism, as well as its utility in ameliorating complications of chronic kidney disease. The company was founded by Jon Isaacsohn and Catherine Pearce on March 28, 2018 and is headquartered in Waltham, MA.